Journal of Diabetes Investigation

Papers
(The H4-Index of Journal of Diabetes Investigation is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Factors associated with hemoglobin glycation index in adults with type 1 diabetes mellitus: The FGM‐Japan study92
Abstracts80
65
Imeglimin, unlike metformin, does not perturb differentiation of human induced pluripotent stem cells towards pancreatic β‐like cells and rather enhances gain in β cell identity gene sets56
Insulin–glucagon‐like peptide‐1 receptor agonist relay and glucagon‐like peptide‐1 receptor agonist first regimens in individuals with type 2 diabetes: A randomized, open‐label trial study50
Association between maternal gestational diabetes mellitus and high‐sensitivity C‐reactive protein levels in 8‐year‐old children: The Yamanashi Adjunct Study of the Japan Environment and Children’s St45
Effect of diabetes and prediabetes on the development of disability and mortality among middle‐aged Japanese adults: A 22‐year follow up of NIPPON DATA9043
Glycated hemoglobin variability and the risk of cardiovascular events in patients with prediabetes and type 2 diabetes mellitus: A post‐hoc analysis of a prospective and multicen41
Association between low‐carbohydrate diets and continuous glucose monitoring‐derived time in ranges40
Effect of glucagon‐like peptide‐1 receptor agonists on fat distribution in patients with type 2 diabetes: A systematic review and meta‐analysis38
Long‐term safety and efficacy of SGLT2 inhibitor use in older east Asians with type 2 diabetes38
Usefulness of subclassification of adult diabetes mellitus among inpatients in Japan37
Effect of the Diabetic Nephropathy Aggravation Prevention Program on medical visit behavior in individuals under the municipal national health insurance34
What is new in metabolic dysfunction‐associated steatotic liver disease?32
Issue Information32
Reply to the comments of Saleh et al. on “Coexistence of high visceral fat area and sarcopenia and atherosclerotic markers in old‐old patients with diabetes: Is there an association?”30
30
Incretin hormones: Revolutionizing the treatment landscape for kidney and liver diseases in type 2 diabetes and obesity27
Effects of switching from MiniMed™ 640G to 770G on continuous glucose monitoring metrics and DTR‐QOL scores: An observational study of Japanese p27
FOSL2 activates TGF‐β1‐mediated GLUT1/mTOR signaling to promote diabetic kidney disease26
Cross‐sectional association of irregular dietary habits with glycemic control and body mass index among people with diabetes26
Glucose‐dependent insulinotropic polypeptide receptor systems in the hypothalamus and the brainstem regulate feeding and weight through distinct pathways25
Prognostic value of longitudinal HbA1c variability in predicting the development of diabetic sensorimotor polyneuropathy among patients with type 2 diabetes mellitus: A prospective cohort o25
Effect of hemoglobin A1c management levels on coronary physiology evaluated by quantitative flow ratio in patients who underwent percutaneous coronary intervention24
Can we catch the second loach employing BACE1 inhibition, even as the first one might be escaping?24
0.062094926834106